Found: 5
Select item for more details and to access through your institution.
Nonclinical Evaluation of PF-06438179: A Potential Biosimilar to Remicade<sup>®</sup> (Infliximab).
- Published in:
- 2016
- By:
- Publication type:
- journal article
Evaluation of Therapeutics for Severely Debilitating or Life‐Threatening Diseases or Conditions: Defining Scope to Enable Global Guidance Development.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 107, n. 3, p. 514, doi. 10.1002/cpt.1673
- By:
- Publication type:
- Article
An Industry Perspective on the 2017 EMA Guideline on First‐in‐Human and Early Clinical Trials.
- Published in:
- Clinical Pharmacology & Therapeutics, 2018, v. 103, n. 4, p. 566, doi. 10.1002/cpt.984
- By:
- Publication type:
- Article
Industry Perspective on Biomarker Development and Qualification.
- Published in:
- Clinical Pharmacology & Therapeutics, 2018, v. 103, n. 1, p. 27, doi. 10.1002/cpt.919
- By:
- Publication type:
- Article
Microphysiological systems in early stage drug development: Perspectives on current applications and future impact.
- Published in:
- Journal of Toxicological Sciences, 2021, v. 46, n. 3, p. 99, doi. 10.2131/jts.46.99
- By:
- Publication type:
- Article